Long-term follow-up of lesion-specific outcomes comparing drug-eluting stents and bare metal stents in diseased saphenous vein grafts

Reviews in Cardiovascular Medicine

Volumn 14, Issue 1, 2013, Pages 1-6

  Runyan, Danielle ^a   Gorges, Rony ^a   Feldman, Dustin ^a   McCullough, Peter A ^a   David, Shukri ^a   Saba, Souheil ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

Bare metal stent; Drug eluting stent; Percutaneous intervention; Restenosis; Saphenous vein graft

Indexed keywords

AGED; BARE METAL STENT; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; VEIN GRAFT DISEASE; VEIN INJURY;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; METALS; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879083235     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0663     Document Type: Review

References (21)

1. Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2006;162:1-209.
2. Alexander JH, Hafley G, Harrington RA, et al; for the PREVENTIV IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446-2454. (Pubitemid 41627922)
3. Nwasokwa ON. Coronary artery bypass graft disease. Ann Intern Med. 1995;123:528-545.
4. Fitzgibbon GM, Kafka HP, Leach, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626.
5. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol. 2001;38:150-154. (Pubitemid 32613842)
6. Savage MP, Douglas JS Jr, Fishman DL, et al; for the Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Eng J Med. 1997;337:740-747. (Pubitemid 27417973)
7. Rodés-Cabau JR, Bertrand OF, Larose E, et al. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate Vein graft Lesion stenting with the Taxus stent and Intravascular ultrasound (VELETI) pilot trial. Circulation. 2009;120:1978-1986.
8. Coolong A, Baim DS, Kuntz RE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008;117:790-797. (Pubitemid 351640680)
9. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-1290. (Pubitemid 34260417)
10. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548-553. (Pubitemid 36961168)
11. Carrozza JP Jr, Mumma M, Breall JA, et al. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol. 2005;46:1677-1683. (Pubitemid 41531622)
12. Dixon SR. Saphenous vein graft protection in a distal embolic protection randomized trial. Paper presented at: Transcatheter Cardiovascular Therapeutics Symposium; October 17-25, 2005; Washington, DC.
13. Mauri L, Cox DA, Hermiller J, et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter trial. J Am Coll Cardiol. 2007;50:1442-1449. (Pubitemid 47494591)
14. Vermeersch P, Agostoni P, Verheye S, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol. 2007;50:261-267. (Pubitemid 47039289)
15. Bansal D, Sachdeva R, Mehta JL, et al. Percutaneous intervention in saphenous vein bypass graft disease. J Am Coll Cardiol. 2008;51:970-971.
16. Ge L, Iakovou I, Sangiorgi GM, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol. 2005;45:989-994. (Pubitemid 40432427)
17. Wöhrle J, Nusser T, Kestler HA, et al. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol. 2007;96:70-76. (Pubitemid 46233208)
18. Hoffmann R, Pohl T, Köster R, et al. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicenter study. Heart. 2007;93:331-334. (Pubitemid 46579523)
19. Lee MS, Shah AP, Aragon J, et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv. 2005;66:507-511. (Pubitemid 41779016)
20. Brilakis ES, Lichtenwalter C, de Lemos JA, et al. A randomized-controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions: the SOS (Stenting Of Saphenous Vein Grafts) Trial. J Am Coll Cardiol. 2009;53:919-928.
21. Clinicaltrials.gov. Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA). http://clinicaltrials.gov/ct2/show/ NCT01121224. Accessed August 23, 2010.